Kalaris Therapeutics, Inc.

KLRS

Kalaris Therapeutics, Inc.

KLRS

Insider Sentiment (TTM):

Last Purchase:2026-05-20Last Sale:2026-03-20Shares Purchased (TTM):724,147Shares Sold (TTM):1,915

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:18,567,104Shares Outstanding:23,723,618Institutional Ownership Pct.:78.26%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	43	34	98	42	88	101	2	2	6	5	90	96
Short Term Investments	50	63	20	35	-	-	0	5	25	54	94	118
Deferred Costs Current	1	0	-	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	1	1	1	3	1	1	1	0	1	3	6
Interest Receivable Current	-	-	-	-	-	-	0	0	0	0	0	0
Assets Current	96	98	119	78	92	102	3	123	130	141	188	220
Deferred Costs	-	-	0	0	0	0	3	-	-	-	-	-
Marketable Securities Noncurrent	-	8	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	1	1	1	2	-	-	0	-	0	2	2	25
Restricted Cash Noncurrent	1	1	0	1	1	1	0	-	1	1	1	1
Other Assets Noncurrent	2	2	1	1	1	0	0	-	-	-	0	1
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	-	-	1
Assets	100	110	122	81	93	103	6	123	131	144	191	248
Liabilities And Stockhold…
Liabilities Convertible P…
Liabilities
Liabilities Current
Workers Compensation Liability Current	-	-	-	-	-	0	-	-	-	-	-	-
Accounts Payable Current	1	1	1	0	4	2	2	0	0	1	7	4
Accrued Liabilities Current	-	-	-	-	-	-	5	1	2	5	10	16
Taxes Payable Current	-	-	-	-	-	-	-	-	-	-	-	0
Convertible Notes Payable Current	-	-	0	0	0	0	20	-	-	-	-	-
Derivative Liabilities Current	-	-	0	0	0	0	1	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	-	-	0	-	1	2	11	13
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	1	-
Liabilities Current	9	8	10	6	8	7	25	1	2	8	28	33
Operating Lease Liability Noncurrent	1	1	1	1	-	-	0	-	8	16	17	20
Liabilities	42	41	43	39	40	39	57	1	11	24	45	53
Temporary Equity Carrying Amount Attributable To P…	-	-	0	0	0	0	46	-	-	-	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	240	239	239	192	191	191	20	818	813	807	802	792
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	-	-	0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-182	-171	-160	-150	-138	-127	-117	-697	-693	-686	-656	-596
Stockholders Equity	58	69	79	42	53	64	-97	-89	-52	-48	146	195
Liabilities And Stockholders Equity	100	110	122	81	93	103	6	123	131	144	191	248
Related Party	-	0	0	0	-0	0	0	-	-	-	1	0
Debt Instrument Unamortized Discount Current	-	-	-	-	-	-	1	-	-	-	-	-
Temporary Equity Par Or Stated Value Per Share	-	-	0	0	0	-	0	-	-	-	-	-
Temporary Equity Shares Authorized	-	-	0	0	0	0	75	-	-	-	-	-
Temporary Equity Shares Issued	-	-	0	0	0	0	43	-	-	-	-	-
Temporary Equity Shares Outstanding	-	-	0	0	0	0	43	-	-	-	-	-
Temporary Equity Liquidation Preference	-	-	0	0	0	-	45	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	86	300	300	300	150	300
Common Stock Shares Issued	24	23	23	19	19	19	1	115	115	115	5	114
Shares Outstanding	24	23	23	19	19	19	1	115	115	115	5	114
Preferred Stock Par Or Stated Value Per Share	-	0	-	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	10	-	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	-	0	-	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	0	-	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.31%	-0.84%	-27.35%	-	-	-	-	-	-	-	-	-
2025	-2.37%	-26.04%	-20.41%	102.63%	191.23%	120.61%	18.65%	67.34%	79.03%	-26.06%	-40.38%	-47.89%
2024	0.40%	-6.67%	2.67%	7.30%	10.06%	10.61%	-7.20%	-16.24%	-24.43%	-12.87%	-32.12%	-71.73%
2023	-	-	-	-	-	-	-11.43%	-56.29%	-61.14%	-4.11%	2.44%	-3.08%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	10.98	12.19	12.23	12.89	11.98	14.31	0.11	86.78	55.08	18.48	6.61	6.65
Quick Ratio	10.76	12.08	12.15	12.70	11.56	14.14	0.07	86.33	54.98	18.38	6.49	6.48
Working Capital	87.18M	90.39M	109.10M	72.12M	84.00M	95.04M	-22.10M	121.12M	127.58M	133.83M	159.27M	186.95M
Leverage & Debt
Debt to Equity	0.73	0.60	0.54	0.94	0.75	0.61	-0.59	-0.02	-0.21	-0.50	0.31	0.27
Interest Coverage TTM	-16.55	-16.50	-10.66	-10.13	-18.95	-14.64	-19.15	-76.87	-201.24	-2,041.45	-	-
Debt Ratio	0.42	0.38	0.35	0.48	0.43	0.38	9.21	0.01	0.08	0.16	0.24	0.21
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.86	-1.86	-2.85	-2.97	-4.37	-18.74	-51.77	-79.01	-85.26	-116.29	-42.09	-1.48
Free Cash Flow Per Share TTM	-1.56	-1.80	-2.53	-1.71	-1.32	-5.82	-15.47	-32.21	-55.60	-73.79	-27.51	-1.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-45.79%	-41.94%	-37.20%	-48.08%	-27.75%	-50.24%	-63.68%	-36.73%	-32.18%	-8.06%	12.87%	-10.43%
EPS Growth (1Y)	-57.40%	-90.08%	-94.50%	-96.25%	-94.88%	-83.89%	23.01%	5,228.93%	4,740.73%	6,435.36%	1,812.33%	-33.19%
Valuation Metrics
P/E TTM	-2.19	-3.10	-2.97	-1.95	-0.61	-0.43	-0.19	-0.24	-0.20	-0.15	-0.37	-33.35
P/B TTM	1.68	2.00	1.63	2.58	0.94	0.51	-0.13	-0.28	-0.43	-0.48	0.49	28.83
Market Cap	96.86M	136.89M	128.86M	108.10M	49.93M	32.55M	12.91M	25.16M	22.05M	22.79M	70.76M	5.63B
Enterprise Value	53.18M	101.96M	30.81M	65.71M	-38.49M	-68.92M	30.81M	23.25M	15.81M	17.57M	-19.36M	5.54B
Calculated Values
Free Cash Flow TTM	-37.08M	-42.71M	-38.57M	-31.91M	-24.72M	-23.59M	-20.67M	-43.55M	-73.70M	-96.85M	-124.45M	-125.29M
Net Debt	-43.67M	-34.93M	-98.05M	-42.39M	-88.43M	-101.47M	17.90M	-1.91M	-6.24M	-5.23M	-90.12M	-96.48M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-20Purchase

Owner: Samsara, Biocapital, L.P.…

Title: -

Shares: 244,300

Price/Share: $4.83

Value: $1,179,969.00

Shares Owned: 2,224,147

Relationship: Director,TenPercentOwner

Ownership: Indirect

2026-03-20Sale

Owner: Hagen, Brett R

Title: Chief Accounting Officer

Shares: 1,915

Price/Share: $6.72

Value: $12,868.80

Shares Owned: -

Relationship: Officer

Ownership: Direct

2025-12-18Purchase

Owner: Samsara, Opportunity Fund…

Title: -

Shares: 479,847

Price/Share: $10.42

Value: $5,000,005.74

Shares Owned: 1,979,847

Relationship: TenPercentOwner

Ownership: Indirect

2025-03-26Sale

Owner: Hagen, Brett R

Title: Chief Accounting Officer

Shares: 907

Price/Share: $8.97

Value: $8,135.79

Shares Owned: 1,925

Relationship: Officer

Ownership: Direct

2025-02-21Sale

Owner: Sinha, Vikas

Title: See Remarks

Shares: 303

Price/Share: $10.08

Value: $3,054.24

Shares Owned: 49,129

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-20	Samsara, Biocapital, L.P.…	Director,TenPercentOwner	-	Indirect	Purchase	244,300	4.83	$1,179,969.00	2,224,147	4
2026-03-20	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	1,915	6.72	$12,868.80	0	4
2025-12-18	Samsara, Opportunity Fund…	TenPercentOwner	-	Indirect	Purchase	479,847	10.42	$5,000,005.74	1,979,847	4
2025-03-26	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	907	8.97	$8,135.79	1,925	4
2025-02-21	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	303	10.08	$3,054.24	49,129	4
2025-02-21	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	96	10.08	$967.68	2,832	4
2025-02-21	Miller, Edward	Officer	General Counsel	Direct	Sale	106	10.08	$1,068.48	6,517	4
2025-01-23	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	129	9.70	$1,251.30	49,432	4
2025-01-23	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	36	9.70	$349.20	2,928	4
2025-01-23	Miller, Edward	Officer	General Counsel	Direct	Sale	52	9.70	$504.40	6,623	4
2025-01-10	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	979	0.44	$430.76	1,139,915	4
2025-01-10	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	332	0.44	$146.08	68,174	4
2025-01-10	Miller, Edward	Officer	General Counsel	Direct	Sale	409	0.44	$179.96	153,541	4
2024-11-19	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	554	0.55	$304.70	68,506	4
2024-11-19	Miller, Edward	Officer	General Counsel	Direct	Sale	432	0.55	$237.60	211,499	4
2024-11-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	8,706	0.55	$4,788.30	723,363	4
2024-11-19	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	3,186	0.55	$1,752.30	1,140,894	4
2024-11-05	Miller, Edward	Officer	General Counsel	Direct	Sale	2,272	0.86	$1,953.92	211,931	4
2024-11-05	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	5,136	0.86	$4,416.96	1,144,080	4
2024-11-05	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	1,655	0.86	$1,423.30	69,060	4
2024-11-05	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	10,609	0.86	$9,123.74	732,069	4
2024-10-22	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	486	0.77	$374.22	70,715	4
2024-10-22	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	1,882	0.77	$1,449.14	1,149,216	4
2024-10-22	Miller, Edward	Officer	General Counsel	Direct	Sale	766	0.77	$589.82	214,203	4
2024-10-21	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	9,752	0.78	$7,606.56	742,678	4
2024-10-03	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	940	0.81	$761.40	1,152,644	4
2024-10-03	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	1,493	0.81	$1,209.33	752,430	4
2024-10-03	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	301	0.81	$243.81	71,680	4
2024-10-03	Miller, Edward	Officer	General Counsel	Direct	Sale	377	0.81	$305.37	215,604	4
2024-08-20	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	5,390	0.74	$3,988.60	753,923	4
2024-08-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	3,091	0.76	$2,349.16	759,313	4
2024-08-19	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	544	0.76	$413.44	71,981	4
2024-08-19	Miller, Edward	Officer	General Counsel	Direct	Sale	422	0.76	$320.72	215,981	4
2024-08-19	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	3,159	0.76	$2,400.84	1,153,584	4
2024-08-05	Miller, Edward	Officer	General Counsel	Direct	Sale	2,323	0.73	$1,695.79	216,403	4
2024-08-05	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	5,251	0.73	$3,833.23	1,156,743	4
2024-08-05	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	10,847	0.73	$7,918.31	762,404	4
2024-08-05	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	1,692	0.73	$1,235.16	72,525	4
2024-07-22	Miller, Edward	Officer	General Counsel	Direct	Sale	757	0.74	$560.18	218,726	4
2024-07-22	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	481	0.74	$355.94	74,217	4
2024-07-22	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	1,858	0.74	$1,374.92	1,161,994	4
2024-07-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	9,731	0.75	$7,298.25	773,251	4
2024-07-02	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	939	0.72	$676.08	1,165,394	4
2024-07-02	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	304	0.72	$218.88	75,177	4
2024-07-02	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	1,489	0.72	$1,072.08	782,982	4
2024-07-02	Miller, Edward	Officer	General Counsel	Direct	Sale	379	0.72	$272.88	220,117	4
2024-05-21	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	5,149	0.79	$4,067.71	784,471	4
2024-05-17	Miller, Edward	Officer	General Counsel	Direct	Sale	420	0.75	$315.00	220,496	4
2024-05-17	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	3,075	0.75	$2,306.25	789,620	4
2024-05-17	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	541	0.75	$405.75	75,481	4
2024-05-17	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	3,143	0.75	$2,357.25	1,129,996	4
2024-05-03	Miller, Edward	Officer	General Counsel	Direct	Sale	2,311	0.80	$1,848.80	220,916	4
2024-05-03	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	4,957	0.80	$3,965.60	1,133,139	4
2024-05-03	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	10,240	0.80	$8,192.00	792,695	4
2024-05-03	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	1,597	0.80	$1,277.60	76,022	4
2024-04-22	Miller, Edward	Officer	General Counsel	Direct	Sale	757	0.75	$567.75	223,227	4
2024-04-22	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	480	0.75	$360.00	77,619	4
2024-04-22	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	1,857	0.75	$1,392.75	1,138,096	4
2024-04-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	9,601	0.75	$7,200.75	802,935	4
2024-04-02	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	1,533	0.77	$1,180.41	812,536	4
2024-04-02	Miller, Edward	Officer	General Counsel	Direct	Sale	368	0.77	$283.36	224,610	4
2024-04-02	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	885	0.77	$681.45	1,141,474	4
2024-04-02	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	281	0.77	$216.37	78,572	4
2024-02-21	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	5,155	0.71	$3,660.05	814,069	4
2024-02-20	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	2,893	0.70	$2,025.10	1,142,359	4
2024-02-20	Miller, Edward	Officer	General Counsel	Direct	Sale	385	0.70	$269.50	224,978	4
2024-02-20	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	494	0.70	$345.80	78,853	4
2024-02-08	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	11,150	0.67	$7,470.50	79,347	4
2024-02-05	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	18,331	0.67	$12,281.77	1,145,252	4
2024-02-05	Miller, Edward	Officer	General Counsel	Direct	Sale	8,869	0.67	$5,942.23	225,363	4
2024-02-05	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	41,421	0.67	$27,752.07	822,321	4
2024-02-05	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	5,792	0.67	$3,880.64	90,497	4
2024-01-23	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	901	0.67	$603.67	96,289	4
2024-01-23	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	3,205	0.67	$2,147.35	1,163,583	4
2024-01-23	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	9,500	0.67	$6,365.00	863,742	4
2024-01-23	Miller, Edward	Officer	General Counsel	Direct	Sale	1,302	0.67	$872.34	234,232	4
2024-01-04	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	310	0.64	$198.40	97,190	4
2024-01-04	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	1,664	0.64	$1,064.96	873,242	4
2024-01-04	Miller, Edward	Officer	General Counsel	Direct	Sale	424	0.64	$271.36	235,534	4
2024-01-04	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	961	0.64	$615.04	1,166,788	4
2023-12-27	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	28,335	0.74	$20,967.90	97,500	4
2023-11-20	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	4,382	1.69	$7,405.58	874,906	4
2023-11-17	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	2,490	1.63	$4,058.70	1,167,749	4
2023-11-17	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	403	1.63	$656.89	125,835	4
2023-10-20	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	357	1.54	$549.78	126,238	4
2023-10-20	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	1,475	1.54	$2,271.50	1,170,239	4
2023-10-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	8,581	1.58	$13,557.98	881,977	4
2023-10-03	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	1,325	1.98	$2,623.50	890,558	4
2023-10-03	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	222	1.98	$439.56	126,953	4
2023-10-03	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	755	1.98	$1,494.90	1,172,946	4
2023-08-18	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	4,055	2.79	$11,313.45	891,883	4
2023-08-17	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	10,516	2.50	$26,290.00	1,173,701	4
2023-08-17	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	1,653	2.50	$4,132.50	127,175	4
2023-07-20	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	342	3.35	$1,145.70	128,828	4
2023-07-20	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	1,437	3.35	$4,813.95	1,184,217	4
2023-07-19	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	8,342	3.56	$29,697.52	907,299	4
2023-07-05	Sinha, Vikas	Director,Officer,TenPercentOwner	See Remarks	Direct	Sale	2,983	3.05	$9,098.15	1,186,852	4
2023-07-05	Brainard, Diana	Director,Officer	Chief Executive Officer	Direct	Sale	5,275	3.05	$16,088.75	915,641	4
2023-06-27	Gilead, Sciences, Inc.	TenPercentOwner	-	Direct	Purchase	2,930,870	3.75	$10,990,762.50	16,635,286	4
2023-06-09	Hagen, Brett R	Officer	Chief Accounting Officer	Direct	Sale	5,045	5.64	$28,453.80	129,512	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.26%

Inst. Shares: 18,567,104

Shares Outstanding: 23,723,618

2025-12-31

117.87%

Inst. Shares: 17,996,162

Shares Outstanding: 15,267,817

2025-09-30

70.70%

Inst. Shares: 13,222,873

Shares Outstanding: 18,701,708

2025-06-30

71.45%

Inst. Shares: 13,362,268

Shares Outstanding: 18,701,286

2025-03-31

Inst. Shares: 13,393,350

Shares Outstanding: 4,053,140

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	18,567,104	23,723,618	78.26%
2025-12-31	17,996,162	15,267,817	117.87%
2025-09-30	13,222,873	18,701,708	70.70%
2025-06-30	13,362,268	18,701,286	71.45%
2025-03-31	13,393,350	4,053,140	-
2024-12-31	37,943,404	1,335,925	-
2024-09-30	44,309,018	1,352,265	-
2024-06-30	45,240,433	1,325,706	-
2024-03-31	45,073,428	1,312,552	-
2023-12-31	33,740,074	4,524,226	-
2023-09-30	46,444,457	113,894,188	40.78%
2023-06-30	46,646,947	94,625,837	49.30%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Kalaris Therapeutics, Inc. (KLRS) — SEC Financial Statements & Analysis

Kalaris Therapeutics, Inc. (KLRS) is a biological products, (no diagnostic substances) company, incorporated in DE. Kalaris Therapeutics, Inc. trades on Nasdaq as: KLRS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Kalaris Therapeutics, Inc. reported a Debt-to-Equity ratio of 0.73x, a Price-to-Book (P/B) ratio of 1.68x (TTM), at a market cap of $96.86M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.73x
P/B TTM: 1.68x
Market Cap: $96.86M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Kalaris Therapeutics, Inc. in?

Kalaris Therapeutics, Inc. (KLRS) operates in the Biological Products, (No Diagnostic Substances) industry.

What is KLRS's market cap?

Kalaris Therapeutics, Inc. (KLRS) has a market capitalization of $96.86M as of 2026-06-30.

What exchange does KLRS trade on?

Kalaris Therapeutics, Inc. (KLRS) trades on the Nasdaq.

Where is Kalaris Therapeutics, Inc. incorporated?

Kalaris Therapeutics, Inc. is incorporated in DE.